Journal of Cardiac Failure
Volume 16, Issue 3 , Pages 211-217 , March 2010

Exercise-Induced Delayed Onset of Left Ventricular Early Relaxation in Association With Coronary Microcirculatory Dysfunction in Patients With Diabetes Mellitus

  • Reiko Mizuno, MD, PhD

      Affiliations

    • Department of General Medicine, Nara Medical University, Nara, Japan
  • ,
  • Shinichi Fujimoto, MD, PhD, FACC

      Affiliations

    • Department of General Medicine, Nara Medical University, Nara, Japan
    • Corresponding Author InformationReprint requests: Shinichi Fujimoto, MD, PhD, FACC, Department of General Medicine, Nara Medical University, 634-8522, 840 Shijo, Kashihara, Nara, Japan. Tel: +81-744-22-3051; Fax: +81-744-24-5739.
  • ,
  • Yoshihiko Saito, MD, PhD, FAHA

      Affiliations

    • First Department of Internal Medicine, Nara Medical University, Nara, Japan
  • ,
  • Shinobu Nakamura, MD, PhD

      Affiliations

    • Department of General Medicine, Nara Medical University, Nara, Japan

Received 27 July 2009 ,Revised 24 September 2009 ,Accepted 28 October 2009.

References 

  1. Pouleur H. Diastolic dysfunction and myocardial energetics. Eur Heart J. 1990;11:30–34
  2. Abraham TP, Belohlavek M, Thomson HL, Pislaru C, Khandheria B, Seward JB, et al. Time to onset of regional relaxation: feasibility, variability and utility of a novel index of regional myocardial function by strain rate imaging. J Am Coll Cardiol. 2002;39:1531–1537
  3. Ehring T, Heusch G. Left ventricular asynchrony: an indicator of regional myocardial dysfunction. Am Heart J. 1990;120:1047–1057
  4. Visner MS, Arentzen CE, Parrish DG, Larson EV, O'Connor MJ, Crumbley AJ, et al. Effects of global ischemia on the diastolic properties of the left ventricle in the conscious dog. Circulation. 1985;71:610–619
  5. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1997;30:1472–1477
  6. Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation. 1995;91:635–640
  7. Kini AS, Kim MC, Moreno PR, Krishnan P, Ivan OC, Sharma SK. Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial). Am J Cardiol. 2008;101:796–800
  8. Mizuno R, Fujimoto S, Saito Y, Nakamura S. Depressed recovery of subendocardial perfusion in persistent heart failure after complete revascularization in diabetic patients with hibernating myocardium. Heart. 2009;95:830–834
  9. Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation. 2001;103:2560–2565
  10. Peltier M, Vancraeynest D, Pasquet A, Ay T, Roelants V, D'hondt AM, et al. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography. Comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J Am Coll Cardiol. 2004;43:257–264
  11. Moir S, Hanekom L, Fang ZY, Haluska B, Wong C, Burgess M, et al. Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart. 2006;92:1414–1419
  12. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994;23:600–606
  13. Arad M, Abboud S, Radai MM, Elion O, Bar-Nachum S, Zohar M, et al. Dynamic beat-to-beat QT-RR relationship during physiotherapy effort in elderly patients without primary heart disease. Pacing Clin Electrophysiol. 1999;22:1240–1244
  14. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97:473–483
  15. Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation. 2005;112:179–184
  16. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol. 2003;41:611–617
  17. Vinereanu D, Nicolaides E, Tweddel AC, Mädler CF, Holst B, Boden LE, et al. Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond). 2003;105:591–599
  18. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008;121:748–757
  19. Opie LH. Mechanisms of cardiac contraction and relaxation. In:  Braunwald E editors. Heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia, PA: W.B. Saunders Company; 2001;p. 443–478
  20. Hajjar RJ, Müller FU, Schmitz W, Schnabel P, Böhm M. Molecular aspects of adrenergic signal transduction in cardiac failure. J Mol Med. 1998;76:747–755
  21. Hasenfuss G, Meyer M, Schillinger W, Preuss M, Pieske B, Just H. Calcium handling proteins in the failing human heart. Basic Res Cardiol. 1997;92:87–93
  22. Mercadier JJ, Lompré AM, Duc P, Boheler KR, Fraysse JB, Wisnewsky C, et al. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 1990;85:305–309
  23. Oltman CL, Richou LL, Davidson EP, Coppey LJ, Lund DD, Yorek MA. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol. 2006;291:H1780–H1787
  24. Given MB, Greenberg SS, Giles TD. Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats. Am J Hypertens. 2001;14:446–454
  25. Strauer BE, Motz W, Vogt M, Schwartzkopff B. Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes. A possible cause for diabetic heart disease in man. Exp Clin Endocrinol Diabetes. 1997;105:15–20
  26. Pitkänen OP, Nuutila P, Raitakari OT, Rönnemaa T, Koskinen PJ, Iida H, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes. 1998;47:248–254
  27. Hansen A, Johansson BL, Wahren J, von Bibra H. C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes. 2002;51:3077–3082
  28. Schindler TH, Facta AD, Prior JO, Cadenas J, Hsueh WA, Quinones MJ, et al. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Heart. 2007;93:345–349
  29. Brown MA, Norris RM, Takayama M, White HD. Post-systolic shortening: a marker of potential for early recovery of acutely ischaemic myocardium in the dog. Cardiovasc Res. 1987;21:703–716
  30. Jamal F, Kukulski T, D'hooge J, De Scheerder I, Sutherland G. Abnormal postsystolic thickening in acutely ischemic myocardium during coronary angioplasty: a velocity, strain, and strain rate Doppler myocardial imaging study. J Am Soc Echocardiogr. 1999;12:994–996

 The authors have no conflicts to disclose.

PII: S1071-9164(09)01145-2

doi: 10.1016/j.cardfail.2009.10.024

Journal of Cardiac Failure
Volume 16, Issue 3 , Pages 211-217 , March 2010